Literature DB >> 29667100

Severe infections in systemic lupus erythematosus: disease pattern and predictors of infection-related mortality.

C L Teh1, S A Wan2, G R Ling3.   

Abstract

Infection is a major cause of morbidity and mortality among patients with systemic lupus erythematosus (SLE). To describe the pattern of serious infections in patients with SLE and to identify the predictors of infection-related mortality among SLE patients with serious infections, we prospectively studied all SLE patients who were hospitalized with infections in Sarawak General Hospital during 2011-2015. Demographic data, clinical features, and outcomes were collected. Cox regression analysis was carried out to determine the independent predictors of infection-related mortality. There were a total of 125 patients with 187 episodes of serious infections. Our patients were of multiethnic origins with female predominance (89.6%). Their mean age was 33.4 ± 14.2 years. The patients had a mean disease duration of 66.8 ± 74.0 months. The most common site of infection was pulmonary (37.9%), followed by septicemia (22.5%). Gram-negative organisms (38.2%) were the predominant isolates within the cohort. There were 21 deaths (11.2%) during the study period. Independent predictors of infection-related mortality among our cohort of SLE patients were flare of SLE (HR 3.98, CI 1.30-12.21) and the presence of bacteremia (HR 2.54, CI 0.98-6.59). Hydroxychloroquine was protective of mortality from serious infections (HR 9.26, CI 3.40-25.64). Pneumonia and Gram-negative organisms were the predominant pattern of infection in our SLE cohort. The presence of flare of SLE and bacteremia were independent prognostic predictors of infection-related mortality, whereas hydroxychloroquine was protective of infection-related mortality among SLE patients with serious infections.

Entities:  

Keywords:  Infection; Mortality; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2018        PMID: 29667100     DOI: 10.1007/s10067-018-4102-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  29 in total

1.  Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group.

Authors:  G S Alarcón; G McGwin; H M Bastian; J Roseman; J Lisse; B J Fessler; A W Friedman; J D Reveille
Journal:  Arthritis Rheum       Date:  2001-04

2.  Infection in Southern Chinese Patients with Systemic Lupus Erythematosus: Spectrum, Drug Resistance, Outcomes, and Risk Factors.

Authors:  Dongying Chen; Jingyi Xie; Haihong Chen; Ying Yang; Zhongping Zhan; Liuqin Liang; Xiuyan Yang
Journal:  J Rheumatol       Date:  2016-06-15       Impact factor: 4.666

3.  Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients.

Authors:  X Bosch; A Guilabert; L Pallarés; R Cerveral; M Ramos-Casals; A Bové; M Ingelmo; J Font
Journal:  Lupus       Date:  2006       Impact factor: 2.911

4.  Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms.

Authors:  D B Hellmann; M Petri; Q Whiting-O'Keefe
Journal:  Medicine (Baltimore)       Date:  1987-09       Impact factor: 1.889

5.  The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea.

Authors:  J E Yun; S W Lee; T H Kim; J B Jun; S Jung; S C Bae; T Y Kim; D H Yoo
Journal:  Clin Exp Rheumatol       Date:  2002 Mar-Apr       Impact factor: 4.473

6.  Severe infections in patients with lupus nephritis treated with immunosuppressants: A retrospective cohort study.

Authors:  Cynthia C Lim; Pei Yun Liu; Hui Zhuan Tan; Peishan Lee; Yok Mooi Chin; Irene Yj Mok; Choong Meng Chan; Jason Cj Choo
Journal:  Nephrology (Carlton)       Date:  2017-06       Impact factor: 2.506

7.  Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality.

Authors:  F Goldblatt; S Chambers; A Rahman; D A Isenberg
Journal:  Lupus       Date:  2009-07       Impact factor: 2.911

Review 8.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

9.  All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre.

Authors:  June Lee; Nimrit Dhillon; Janet Pope
Journal:  Rheumatology (Oxford)       Date:  2013-01-09       Impact factor: 7.580

10.  Predictors of major infections in systemic lupus erythematosus.

Authors:  Guillermo Ruiz-Irastorza; Nerea Olivares; Ioana Ruiz-Arruza; Agustin Martinez-Berriotxoa; Maria-Victoria Egurbide; Ciriaco Aguirre
Journal:  Arthritis Res Ther       Date:  2009-07-15       Impact factor: 5.156

View more
  10 in total

1.  Survival analysis of patients with Sjögren's syndrome in Turkey: a tertiary hospital-based study.

Authors:  Veli Yazisiz; Mesut Göçer; Funda Erbasan; İsmail Uçar; Bengisu Aslan; Şuayp Oygen; Edip Gökalp Gök; Mustafa Ender Terzioğlu
Journal:  Clin Rheumatol       Date:  2019-09-25       Impact factor: 2.980

2.  Infection mitigation a necessity in lupus patients.

Authors:  Peiyun Liu; Hui Zhuan Tan; Huihua Li; Jason Chon Jun Choo; Cynthia Ciwei Lim
Journal:  Clin Rheumatol       Date:  2018-10-23       Impact factor: 2.980

3.  Lymphocyte subset clustering analysis in treatment-naive patients with systemic lupus erythematosus.

Authors:  Zhimin Lu; Weiping Li; Yawei Tang; Zhanyun Da; Xia Li
Journal:  Clin Rheumatol       Date:  2020-10-31       Impact factor: 2.980

4.  A large-scale investigation into the role of classical HLA loci in multiple types of severe infections, with a focus on overlaps with autoimmune and mental disorders.

Authors:  Ron Nudel; Rosa Lundbye Allesøe; Wesley K Thompson; Thomas Werge; Simon Rasmussen; Michael E Benros
Journal:  J Transl Med       Date:  2021-05-31       Impact factor: 5.531

5.  Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic.

Authors:  Hans-Joachim Anders; Annette Bruchfeld; Gema Maria Fernandez Juarez; Jürgen Floege; Dimitrios Goumenos; Kultigin Turkmen; Cees van Kooten; Vladimir Tesar; Mårten Segelmark
Journal:  Nephrol Dial Transplant       Date:  2020-06-01       Impact factor: 5.992

6.  Associated clinical factors for serious infections in patients with systemic lupus erythematosus.

Authors:  Ju-Yang Jung; Dukyong Yoon; Young Choi; Hyoun-Ah Kim; Chang-Hee Suh
Journal:  Sci Rep       Date:  2019-07-04       Impact factor: 4.379

7.  Mortality risk prediction in lupus patients complicated with invasive infection in the emergency department: LUPHAS score.

Authors:  Wanlong Wu; Jun Ma; Yuhong Zhou; Chao Tang; Feng Zhao; Fangfang Sun; Wenwen Xu; Jie Chen; Shuang Ye; Yi Chen
Journal:  Ther Adv Musculoskelet Dis       Date:  2019-11-05       Impact factor: 5.346

Review 8.  The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug.

Authors:  Juan M Mejía-Vilet; Isabelle Ayoub
Journal:  Front Med (Lausanne)       Date:  2021-02-16

Review 9.  Central nervous system infections in patients with systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  Kasra Molooghi; Fereshte Sheybani; Hamidreza Naderi; Zahra Mirfeizi; Negar Morovatdar; Ashkan Baradaran
Journal:  Lupus Sci Med       Date:  2022-01

10.  Sepsis Mortality Is high in Patients With Connective Tissue Diseases Admitted to the Intensive Care Unit (ICU).

Authors:  Marco Krasselt; Christoph Baerwald; Sirak Petros; Olga Seifert
Journal:  J Intensive Care Med       Date:  2021-02-25       Impact factor: 3.510

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.